A year after British pharmaceutical giant, GlaxoSmithKline exited Nigeria and asthmatic patients who depended on its inhalers ...
With an estimated 2.1 million children in Nigeria and almost one million in Ethiopia[1] classed as 'zero dose', having never received a routine vaccination, the Save the Children Immunisation ...
Two innovative projects in Nigeria and Ethiopia have received significant funding from Save the Children through its Immunisation Accelerator, supported by ...
GSK's generous funding allows Save the Children to respond immediately ... including our biggest programs in the Democratic Republic of Congo, Ethiopia, Kenya, Nigeria and Yemen. Together, we are ...
These are businesses that are doing supplies to GSK. ‘’Once GSK leaves Nigeria, we have incapacitated 1,000 able-bodied Nigerians from their ability to generate income. We have incapacitated ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK is nearing a $1bn deal to buy a US biotech developing a treatment for rare gastrointestinal tumours ...